Innate Pharma announces its financial calendar for 2013 as well as its participation to upcoming investor conferences

Innate Pharma SA (Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, announces today its tentative financial calendar for 2013.

During the first quarter of 2013, Innate Pharma management will be present at the following investor conferences:

• JP Morgan Healthcare conference - San Francisco, January 7, 8 & 9, 2013;
• Oddo Midcap Forum –   Lyon, January 11, 2013;
• Credit Suisse London One-on-One Healthcare Conference –  London, March 6, 2013.